Flow cytometric chemosensitivity assay using JC-1, a sensor of mitochondrial transmembrane potential, in acute leukemia

Cancer Chemotherapy and Pharmacology

Volumn 72, Issue 6, 2013, Pages 1335-1342

  Yokosuka, Tomoko ^a   Goto, Hiroaki ^a   Fujii, Hisaki ^a   Naruto, Takuya ^a   Takeuchi, Masanobu ^a   Tanoshima, Reo ^a   Kato, Hiromi ^a   Yanagimachi, Masakatsu ^a   Kajiwara, Ryosuke ^a   Yokota, Shumpei ^a  

^a YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Acute leukemia; Chemosensitivity assay; Chemotherapy; Children; Drug resistance; Flow cytometry; JC 1

Indexed keywords

5,50,6,60 TETRACHLORO 1,10,3,30 TETRAETHYL BENZIMIDAZOLO CARBOCYANINE IODIDE; ASPARAGINASE; BORTEZOMIB; CARBOCYANINE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FIRTECAN; FLUDARABINE; LIPOCORTIN 5; PREDNISOLONE; TOPOTECAN; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; APOPTOSIS; ARTICLE; BIOSENSOR; CELL MEMBRANE DEPOLARIZATION; CELL SURVIVAL; CHEMOSENSITIVITY; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FLOW CYTOMETRIC CHEMOSENSITIVITY ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; RELIABILITY; SCHOOL CHILD; SENSITIVITY ANALYSIS;

ADOLESCENT; ANNEXIN A5; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZIMIDAZOLES; CARBOCYANINES; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; MEMBRANE POTENTIAL, MITOCHONDRIAL; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84890408637     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-013-2303-x     Document Type: Article

References (36)

1. Pui CH, Robison LL, Look AT (2008) Acute lymphoblastic leukaemia. Lancet 371:1030-1043
2. Salzer WL, Devidas M, Carroll WL, Winick N, Pullen J, Hunger SP, Camitta BA (2010) Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group. Leukemia 24:355-370
3. Gaynon PS, Angiolillo AL, Carroll WL, Nachman JB, Trigg ME, Sather HN, Hunger SP, Devidas M (2010) Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report. Leukemia 24:285-297
4. Moricke A, Zimmermann M, Reiter A et al (2010) Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 24:265-284
5. Pieters R, Klumper E, Kaspers GJ, Veerman AJ (1997) Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia. Crit Rev Oncol Hematol 25:11-26
6. Bosanquet AG (1991) Correlations between therapeutic response of leukaemias and in vitro drug-sensitivity assay. Lancet 337:711-714
7. Pieters R, Huismans DR, Loonen AH, Hahlen K, van der Does-van den Berg A, van Wering ER, Veerman AJ (1991) Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia. Lancet 338:399-403
8. Hongo T, Yajima S, Sakurai M, Horikoshi Y, Hanada R (1997) In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. Blood 89:2959-2965
9. Okada S, Hongo T, Yamada S et al (2003) In vitro efficacy of l-asparaginase in childhood acute myeloid leukaemia. Br J Haematol 123:802-809
10. Kaspers GJ, Veerman AJ, Pieters R, Van Zantwijk CH, Smets LA, Van Wering ER, Der Does-Van Van, Den Berg A (1997) In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood 90:2723-2729
11. Zwaan CM, Kaspers GJ, Pieters R et al (2002) Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities. Blood 100:3352-3360
12. Zhong Y, Bakke AC, Fan G et al (2007) Drug resistance in B-cell chronic lymphocytic leukemia: predictable by in vitro evaluation with a multiparameter flow cytometric cytotoxicity assay. Cytometry B Clin Cytom 72:189-195
13. Galderisi F, Stork L, Li J, Mori M, Mongoue-Tchokote S, Huang J (2009) Flow cytometric chemosensitivity assay as a predictive tool of early clinical response in acute lymphoblastic leukemia. Pediatr Blood Cancer 53:543-550
14. Savasan S, Buck S, Ozdemir O, Hamre M, Asselin B, Pullen J, Ravindranath Y et al (2005) Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia. Leuk Lymphoma 46:833-840
15. Legrand O, Perrot JY, Simonin G, Baudard M, Marie JP et al (2001) JC-1: a very sensitive fluorescent probe to test Pgp activity in adult acute myeloid leukemia. Blood 97:502-508
16. Goto H, Naruto T, Tanoshima R, Kato H, Yokosuka T et al (2009) Chemo-sensitivity in a panel of B-cell precursor acute lymphoblastic leukemia cell lines, YCUB series, derived from children. Leuk Res 33:1386-1391
17. Manabe A, Ohara A, Hasegawa D et al (2008) Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15. Haematologica 93:1155-1160
18. Tsuchida M, Ohara A, Manabe A et al (2010) Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999. Leukemia 24:383-396
19. Fulda S, Debatin KM (2006) Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25:4798-4811
20. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770-776
21. Chaoui D, Faussat AM, Majdak P et al (2006) JC-1, a sensitive probe for a simultaneous detection of P-glycoprotein activity and apoptosis in leukemic cells. Cytometry B Clin Cytom 70:189-196
22. Frost BM, Nygren P, Gustafsson G et al (2003) Increased in vitro cellular drug resistance is related to poor outcome in high-risk childhood acute lymphoblastic leukaemia. Br J Haematol 122:376-385
23. Den Boer ML, Harms DO, Pieters R et al (2003) Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. J Clin Oncol 21:3262-3268
24. Riehm H, Reiter A, Schrappe M, Berthold F, Dopfer R, Gerein V et al (1987) Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83). Klin Paediatr 199:151-160
25. Reiter B, Schrappe AM, Ludwig WD, Hiddemann W, Sauter S, Henze G et al (1994) Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALLBFM 86. Blood 84:3122-3133
26. Duval M, Suciu S, Ferster A, Rialland X, Nelken B, Benoit Y et al (2002) Comparison of Escherichia coliasparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial. Blood 99:2734-2739
27. Arico M, Valsecchi MG, Conter V, Rizzari C, Pession A, Messina C et al (2002) Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt- Mu''enster protocol II. Blood 100:420-426
28. Kamps WA, Bokkerink JP, Hakvoort-Cammel FG, Veerman AJ, Weening RS, van Wering ER et al (2002) BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996). Leukemia 16:1099-1111
29. Manabe A, Ohara A, Hasegawa D, Koh K, Saito T, Kiyokawa N, Kikuchi A, Takahashi H, Ikuta K, Hayashi Y, Hanada R, Tsuchida M, Tokyo Children's Cancer Study Group (2008) Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15. Haematologica 93:1155-1160
30. Kaspers GJ, Pieters R, Van Zantwijk CH, Van Wering ER, Van Der Does-Van Den Berg A, Veerman AJ (1998) Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs. Blood 92:259-266
31. Riehm H, Reiter A, Schrappe M et al (1987) Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83). Klin Padiatr 199:151-160
32. Reiter A, Schrappe M, Ludwig WD et al (1994) Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84:3122-3133
33. Adams J, Behnke M, Chen S et al (1998) Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. Bioorg Med Chem Lett 8:333-338
34. Panetta JC, Yanishevski Y, Pui CH et al (2002) A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemia. Cancer Chemother Pharmacol 50:419-428
35. Kager L, Cheok M, Yang W et al (2005) Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics. J Clin Invest 115:110-117
36. Burger JA, Peled A (2009) CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia 23:43-52